Denmark booms on back of US exports

Related tags Denmark Sweden

Danish pharmaceutical companies increased their sales to overseas
countries by 20 per cent in the first four months of this year
compared with the same period of 2002, according to Invest In
Denmark.

Danish pharmaceutical companies increased their sales to overseas countries by 20 per cent in the first four months of this year compared with the same period of 2002, according to Invest In Denmark.

Progress in medical exports has been most marked in the US with a growth of 50 per cent in relation to the same period in 2002. Invest In Denmark​ is likely that medical exports to the US in 2003 will top DKK 5 billion (€673 million) compared with last year's exports of DKK 4.3 billion.

The vast majority of total exports of medicine go to the USA, Germany, the UK, Sweden and France, which together buy 50 per cent of all Danish medical exports - compared with around 40 per cent 10 years ago, according to a report in local newspaper Børsen.

The pharmaceutical industry is currently Denmark's most important export sector with earnings of just over DKK 30 billion annually out of total exports of DKK 442 billion.

Related news

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Follow us

Products

View more

Webinars